Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids for Severe PJP in Non-HIV Immunocompromised Patients
NCT07152613Phase 3Not yet recruiting
- Sponsor
- Qingyuan Zhan
- Start
- Sep 2025
- Primary completion
- Jun 2027
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of methylprednisolone injection in Pneumocystis jirovecii pneumonia (PJP), sponsored by Qingyuan Zhan. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
methylprednisolone injection
03
Conditions
Pneumocystis jirovecii pneumonia (PJP)
Beyond the preview
Go deeper on NCT07152613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07152613.